- March 1, 2019
US FDA warns CanaRx for selling unapproved, misbranded and unsafe imported drugs to unsuspecting Americans
The U.S. Food and Drug Administration posted a warning letter to CanaRx for facilitating the distribution of unapproved new drugs and misbranded drugs to U.S. consumers. These drugs are potentially dangerous to U.S. consumers.
CONTINUE READING ON www.fda.gov